SCHEDULE 13DAccepted Oct 5, 5:35 PM ET
ADARx Pharmaceuticals, Inc. SCHEDULE 13D
Accepted (ET)
5:35 PM
Oct 5, 2026
Filed
Oct 5, 2026
Documents
3
Size
179.2 KB
Summary
Summary not available
This filing does not have a written summary yet. You can still open the original filing and its exhibits.